What Embryo Testing Can and Cannot Tell Prospective Parents

Genetic testing of embryos is often discussed as though it provides a simple answer about which embryo will lead to a healthy baby. The reality is more nuanced. Preimplantation genetic testing refers to several forms of testing performed on embryos created through IVF, and the purpose, evidence and limitations differ according to the type being used.

Understanding those distinctions helps patients ask better questions and avoids treating all embryo testing as one universal procedure.

Different Tests Answer Different Questions

PGT-M is used when there is a known risk of passing on a condition caused by a change in a particular gene. The laboratory develops a test around the family’s specific genetic information, which means preparation may begin before the IVF cycle itself.

PGT-SR is intended for people with certain structural chromosome rearrangements. These can affect the balance of genetic material within an embryo and may be associated with miscarriage or affected pregnancies.

PGT-A assesses the number of chromosomes in sampled embryo cells. It is sometimes offered as a way to help select embryos for transfer, but it is not the same as testing for a particular inherited disease. Patients should ask why it is being recommended in their own case and what evidence supports its use for people with similar circumstances.

The older term PGD is still encountered, particularly in clinic materials, but modern terminology usually separates testing by purpose more clearly.

Testing Requires an IVF Cycle

Embryo testing cannot be carried out without first creating embryos through IVF. This generally involves ovarian stimulation, egg collection, fertilisation and several days of laboratory development.

A small number of cells are then removed from an embryo at an appropriate developmental stage and sent for analysis. The embryo is commonly frozen while the result is awaited, with transfer considered later.

Not every egg becomes an embryo, and not every embryo develops far enough to be tested. Testing can then identify embryos that are unsuitable according to the purpose of the test, leaving some patients without an embryo available for transfer.

This possibility should be discussed before treatment begins, particularly when ovarian reserve or expected embryo numbers are low.

A Result Is Not a Guarantee

Embryo testing can reduce specific risks or provide information that guides selection, but it cannot rule out every genetic, developmental or pregnancy complication.

The biopsy samples cells that later contribute mainly to the placenta, and embryos can contain more than one cell line. This biological complexity means that results are not always perfectly straightforward. Clinics should explain how uncertain or mosaic findings are handled and whether specialist genetic counselling is available.

Patients may still be advised to consider prenatal screening or diagnostic testing during pregnancy. A tested embryo should not be interpreted as a guarantee that no health problem can occur.

The accuracy and limitations of the laboratory method should form part of informed consent rather than appearing only after an unexpected result.

Genetic Counselling Helps Put the Information in Context

When testing concerns an inherited condition or chromosome rearrangement, genetic counselling can help patients understand the chance of transmission, the possible results and the choices that may follow.

The discussion should include personal values as well as technical information. Different families may make different decisions when faced with uncertainty, and there is not always one medically obvious answer.

Costs, additional laboratory time and the likelihood of obtaining transferable embryos should also be reviewed. Patients need to understand the whole pathway rather than considering the test as a small add-on to an otherwise unchanged cycle.

Embryo testing can be valuable when it answers a clearly defined clinical question. Its responsible use begins with understanding which test is proposed, why it fits the family’s circumstances and what uncertainty will remain after the result is received.